Literature DB >> 19935009

Endoscopic transnasal resection of ectopic esthesioneuroblastoma in the pterygopalatine fossa: technical case report.

Satoru Kodama1, Toshiaki Kawano, Masashi Suzuki.   

Abstract

OBJECTIVE: Esthesioneuroblastoma is a rare, malignant neoplasm arising from the olfactory neuroepithelium in the upper nasal cavity. Even more rare is ectopic esthesioneuroblastoma developing from the region outside the olfactory epithelium. In addition, tumors occurring in the pterygopalatine fossa (PPF) are uncommon, and the endoscopic transnasal approach for the resection of malignant tumors in this region is also uncommon. CLINICAL
PRESENTATION: We describe an esthesioneuroblastoma arising from the left maxillary sinus and PPF. The tumor was resected using the endoscopic transnasal approach, followed by treatment with radiotherapy. The patient showed no evidence of recurrence 12 months postoperatively. TECHNIQUE: The endoscopic transnasal approach could be successfully used for the complete removal of malignant tumors in the PPF.
CONCLUSION: The PPF is an anatomic area that is difficult to access. The endoscopic transnasal approach improves access and visualization; it also has the potential to reduce complications compared with the open approach. The endoscopic transnasal approach might become the treatment of choice for malignant tumors in the PPF.

Entities:  

Mesh:

Year:  2009        PMID: 19935009     DOI: 10.1227/01.NEU.0000346268.69786.88

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Isolated primary maxillary sinus esthesioneuroblastoma presenting as idiopathic syndrome of inappropriate antidiuretic hormone.

Authors:  Eugene Wong; Siamak Choroomi; Carsten E Palme; Narinder Pal Singh
Journal:  BMJ Case Rep       Date:  2019-05-28

2.  Bilateral Synchronous Ectopic Ethmoid Sinus Olfactory Neuroblastoma: A Case Report.

Authors:  Elena Leon-Soriano; Carolina Alfonso; Laura Yebenes; Julio Garcia-Polo; Luis Lassaletta; Javier Gavilan
Journal:  Am J Case Rep       Date:  2016-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.